Kendomycin  (Synonyms: (-)-TAN2162)

Kendomycin ((−)-TAN 2162) is a polyketide antibiotic with remarkable antibacterial and cancer cells cytotoxic activities. Kendomycin tends to be bacteriostatic rather than bactericidal and inhibits the growth of the methicillin-resistant Staphylococcus aureus (MRSA) strain COL at a low concentration (MIC of 5 μg/mL). Kendomycin is a potent antagonist of the endothelin receptor and a calcitonin receptor agonist which plays its role as an anti-osteoporotic agent^[1][2].

486.64

C₂₉H₄₂O₆

183202-73-5

OC(C1=O)=C([[email protected]]([[email protected]@H]([[email protected]]2O)C)([H])O[[email protected]@](CC[[email protected]@H]3C)([H])[[email protected]@H]2C)C(C(O4)=C1C)=C[[email protected]@]4([[email protected]](C[[email protected]@H](C/C(C)=C/3)C)C)O

Room temperature in continental US; may vary elsewhere.

Please store the product under the recommended conditions in the Certificate of Analysis.

• [1]. Yasser A Elnakady, et al. Investigations to the Antibacterial Mechanism of Action of Kendomycin. PLoS One. 2016 Jan 21;11(1):e0146165.  [Content Brief]

  [2]. Yu Yuan, et al. Total synthesis of kendomycin: a macro-C-glycosidation approach. J Am Chem Soc. 2004 Nov 17;126(45):14720-1.  [Content Brief]

  [3]. Tetsuya Sengoku, et al. Total synthesis of the antibiotic kendomycin: a macrocyclization using the Tsuji-Trost etherification. Angew Chem Int Ed Engl. 2014 Apr 14;53(16):4213-6.  [Content Brief]